Medical Condition

radiotherapy

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 3, Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for radiotherapy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — radiotherapy Clinical Trials

How many clinical trials are currently recruiting for radiotherapy?

ClinicalMetric currently tracks 11 actively recruiting clinical trials for radiotherapy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for radiotherapy?

radiotherapy research spans Phase 2 (2 trials), Phase 3 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a radiotherapy clinical trial?

Eligibility criteria for radiotherapy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Top Sponsors

Fudan University 2 trials

West China Hospital 1 trial

Marmara University 1 trial

Washington University School of Medicine 1 trial

Shanghai Chest Hospital 1 trial

Recruiting Clinical Trials

NCT07020247 Phase 3

Recruiting

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases

Nutritional Status of Head and Neck Cancer Patients

Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen

Washington University School o...

View Trial →

NCT07565532

Recruiting

Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment

Shanghai Chest Hospital

View Trial →

NCT06676449 Phase 3

Recruiting

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Hubei Cancer Hospital

View Trial →

NCT06506838 Phase 4

Recruiting

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

Guangdong Provincial People's ...

View Trial →

NCT07058948 Phase 2

Recruiting

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

Tianjin Medical University Can...

View Trial →

NCT06752239 Phase 3

Recruiting

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

Jiangxi Provincial Cancer Hosp...

View Trial →

NCT06765616 Phase 2

Recruiting

Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer

Related Conditions

immunotherapy (4) locally advanced rectal cancer larc (1) total neoadjuvant therapy (1) anal function preservation (1) breast cancer (1) head and neck cancer (1) nutritional status (1) radiotherapy image guided (1) small cell lung cancer sclc (1) personalized cancer treatment (1) esophageal carcinoma (1) advanced non small cell squamous lung cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology